Mangrove Partners IM, LLC 13D and 13G filings for Anebulo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-17 4:51 pm Purchase |
2024-12-31 | 13G | Anebulo Pharmaceuticals, Inc. ANEB |
Mangrove Partners IM, LLC | 2,525,252 6.150% |
2,525,252 (New Position) |
Filing |